These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17139190)

  • 1. Changes in osmolal gap and osmolality in children with chronic and end-stage renal failure.
    Dursun H; Noyan A; Cengiz N; Attila G; Buyukcelik M; Soran M; Seydaoglu G; Bayazit AK; Anarat A
    Nephron Physiol; 2007; 105(2):p19-21. PubMed ID: 17139190
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of small molecule removal in the control of treatment morbidity with haemodialysis and haemofiltration.
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1981; 18():249-55. PubMed ID: 7329970
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in serum osmolality during hemodialysis of patients with chronic renal insufficiency (author's transl)].
    Loutocký A; Lachmanová J; Tomásek R; Horký K
    Cas Lek Cesk; 1977 Feb; 116(6):177-81. PubMed ID: 851974
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of sodium dialysate variation on hemodynamic stability.
    Aguilera D; Diab N; Faivre JM
    Kidney Int Suppl; 1988 Sep; 25():S187-9. PubMed ID: 3184609
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of the osmolal gap to guide the start and duration of dialysis in methanol poisoning.
    Hunderi OH; Hovda KE; Jacobsen D
    Scand J Urol Nephrol; 2006; 40(1):70-4. PubMed ID: 16452060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiuretic hormone in end-stage renal disease.
    Vaziri ND; Skowsky R; Saiki J
    J Dial; 1980; 4(2-3):73-81. PubMed ID: 7440845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dialysate composition on cardiovascular function in isovolaemic haemodialysis.
    Wehle B; Asaba H; Castenfors J; Gunnarsson B; Bergström J
    Proc Eur Dial Transplant Assoc; 1981; 18():153-9. PubMed ID: 7329963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of continuous blood volume monitoring.
    Lopot F
    EDTNA ERCA J; 1996; 22(4):7-11. PubMed ID: 10723339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium activity, sodium concentration, and osmolality in plasma in acute and chronic renal failure.
    Langhoff E; Ladefoged J
    Clin Chem; 1985 Nov; 31(11):1811-4. PubMed ID: 4053350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the plasma concentration of antidiuretic hormone in chronic renal insufficiency during hemodialysis].
    Horký K; Srámková J; Lachmanová J; Tomásek R; Dvoráková J
    Cas Lek Cesk; 1977 Nov; 116(47):1449-55. PubMed ID: 597830
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma inorganic sulfate in children with chronic renal failure.
    Michalk D; Klare B; Manz F; Schärer K
    Clin Nephrol; 1981 Jul; 16(1):8-12. PubMed ID: 7273497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malondialdehyde concentration in the serum of children with chronic renal failure, chronic hemodialysis and kidney transplantation].
    Otting U; Hellmann C
    Z Urol Nephrol; 1990 Mar; 83(3):141-8. PubMed ID: 2356668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Haemodialysis in children (author's transl)].
    Wolf A; Balzar E; Pinggera WF; Stummvoll HK
    Wien Klin Wochenschr; 1980 Jan; 92(2):35-42. PubMed ID: 6990630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How should dialysis fluid be individualized for the chronic hemodialysis patient? Sodium.
    Flanigan MJ
    Semin Dial; 2008; 21(3):226-9. PubMed ID: 18363598
    [No Abstract]   [Full Text] [Related]  

  • 15. Osmolal gap in hemodialyzed uremic patients.
    Griveas I; Gompou A; Kyritsis I; Papatheodorou G; Agroyannis I; Tsakoniatis M; Kapeleris E; Vrachnes S
    Artif Organs; 2012 Jan; 36(1):16-20. PubMed ID: 21848936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma renin activity and total peripheral resistance in chronic end-stage renal disease (author's transl)].
    Skrabal F; Aigner A; Dittrich P
    Wien Klin Wochenschr; 1974 Oct; 86(19):564-6. PubMed ID: 4372811
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epidemiological profile of end stage renal disease at the Military Hospital in Rabat, Morocco].
    Asserraji M; Maoujoud O; Belarbi M; Oualim Z
    Pan Afr Med J; 2015; 20():439. PubMed ID: 26309471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of plasma vasopressin in patients undergoing chronic hemodialysis.
    Shimamoto K; Watarai I; Miyahara M
    J Clin Endocrinol Metab; 1977 Oct; 45(4):714-20. PubMed ID: 914976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous contrast agents and associated changes in serum osmolality.
    George M; Shannon M
    Pediatr Emerg Care; 2009 Sep; 25(9):555-7. PubMed ID: 19755886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis therapy in children.
    Mehta KP
    J Indian Med Assoc; 2001 Jul; 99(7):368-73. PubMed ID: 11881847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.